These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18374552)

  • 21. Pharmacokinetics evaluation of soft agglomerates for prompt delivery of enteric pantoprazole-loaded microparticles.
    Raffin RP; Colomé LM; Hoffmeister CR; Colombo P; Rossi A; Sonvico F; Colomé LM; Natalini CC; Pohlmann AR; Costa TD; Guterres SS
    Eur J Pharm Biopharm; 2010 Feb; 74(2):275-80. PubMed ID: 19969078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pharmaceutical excipients on aqueous stability of rabeprazole sodium.
    Ren S; Park MJ; Sah H; Lee BJ
    Int J Pharm; 2008 Feb; 350(1-2):197-204. PubMed ID: 17928178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S; Wongwanakul P
    J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrospun zein/eudragit nanofibers based dual drug delivery system for the simultaneous delivery of aceclofenac and pantoprazole.
    Karthikeyan K; Guhathakarta S; Rajaram R; Korrapati PS
    Int J Pharm; 2012 Nov; 438(1-2):117-22. PubMed ID: 22960320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of post-emulsification freeze drying or spray drying processes for the microencapsulation of plasmid DNA.
    Lane ME; Brennan FS; Corrigan OI
    J Pharm Pharmacol; 2005 Jul; 57(7):831-8. PubMed ID: 15969941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eudragit S100 microparticles containing Spodoptera frugiperda nucleopolyehedrovirus: physicochemical characterization, photostability and in vitro virus release.
    Villamizar L; Barrera G; Cotes AM; Martínez F
    J Microencapsul; 2010; 27(4):314-24. PubMed ID: 19839785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the proton pump inhibitor pantoprazole to modify the distribution and activity of doxorubicin: a potential strategy to improve the therapy of solid tumors.
    Patel KJ; Lee C; Tan Q; Tannock IF
    Clin Cancer Res; 2013 Dec; 19(24):6766-76. PubMed ID: 24141627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of a chiral liquid chromatography-tandem mass spectrometry method for the determination of pantoprazole in dog plasma.
    Chen M; Xia Y; Ma Z; Li L; Zhong D; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 906():85-90. PubMed ID: 22959824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of omeprazole degradation by enteric coating polymers: an UV-VIS spectroscopy study.
    Riedel A; Leopold CS
    Pharmazie; 2005 Feb; 60(2):126-30. PubMed ID: 15739901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of emulsification and spray-drying microencapsulation on the antilisterial activity of transcinnamaldehyde.
    Trinh NT; Lejmi R; Gharsallaoui A; Dumas E; Degraeve P; Thanh ML; Oulahal N
    J Microencapsul; 2015; 32(7):719-23. PubMed ID: 26398167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spray-drying enteric polymers from aqueous solutions: a novel, economic, and environmentally friendly approach to produce pH-responsive microparticles.
    Alhnan MA; Kidia E; Basit AW
    Eur J Pharm Biopharm; 2011 Oct; 79(2):432-9. PubMed ID: 21439376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
    Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
    Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
    Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
    J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P; van Zanten SV; Mattsson H; Wernersson B
    Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers.
    Chen CC; Lee JY; Fang YJ; Hsu SJ; Han ML; Tseng PH; Liou JM; Hu FC; Lin TL; Wu MS; Wang HP; Lin JT
    Aliment Pharmacol Ther; 2012 Apr; 35(8):894-903. PubMed ID: 22369682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
    Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A
    Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in chirally pure proton pump inhibitors.
    Pai V; Pai N
    J Indian Med Assoc; 2007 Aug; 105(8):469-70, 472, 474. PubMed ID: 18236913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.